Lipid a radiosensitizes hypoxic EMT-6 tumor cells: Role of the NF-κB signaling pathway

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 3, 2003, Pages 779-786

  De Ridder, Mark ^a   Verovski, Valeri N ^a   Van Den Berge, Dirk L ^a   Sermeus, Alexandra B L ^a   Monsaert, Christinne ^a   Wauters, Nathalie ^a   Storme, Guy A ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

COX 2; iNOS; Lipid A; NF B; Radiosensitivity

Indexed keywords

BIOASSAY; CELLS; IMMUNOLOGY; LIPIDS; RADIOTHERAPY; TUMORS;

CLONOGENIC SURVIVAL;

ONCOLOGY;

AMINOGUANIDINE; ARSENOSOBENZENE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID A; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVATION; ENZYME ANALYSIS; HYPOXIC CELL; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR CELL; UPREGULATION; WESTERN BLOTTING;

EID: 0141838865     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00662-X     Document Type: Article

References (42)

1. Engelhardt R., Mackensen A., Galanos C. Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res. 51:1991;2524-2530.
2. Shimizu T., Iida K., Iwamoto Y., et al. Biological activities and antitumor effects of synthetic lipid A analog linked N-acylated serine. Int J Immunopharmacol. 17:1995;425-431.
3. Kiani A., Tschiersch A., Gaboriau E., et al. Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients. Blood. 90:1997;1673-1683.
4. de Bono J.S., Dalgleish A.G., Carmichael J., et al. Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide. Clin Cancer Res. 6:2000;397-405.
5. Lien E., Chow J.C., Hawkins L.D., et al. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J Biol Chem. 276:2001;1873-1880.
6. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13:2001;85-94.
7. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 177:1993;1779-1784.
8. Rhee S.H., Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem. 275:2000;34035-34040.
9. Wink D.A., Vodovotz Y., Laval J., et al. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711-721.
10. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 1:2001;11-21.
11. Hanson W.R., Thomas C. 16, 16-dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat Res. 96:1983;393-398.
12. Kishi K., Petersen S., Petersen C., et al. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res. 60:2000;1326-1331.
13. Pyo H., Choy H., Amorino G.P., et al. NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res. 7:2001;2998-3005.
14. Houchen C.W., Sturmoski M.A., Anant S., et al. Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine. Am J Physiol Gastrointest Liver Physiol. 284:2003;G490-G498.
15. Milas L., Hanson W.R. Eicosanoids and radiation. Eur J Cancer. 31A:1995;1580-1585.
16. Raju U., Nakata E., Yang P., et al. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme Mechanistic considerations . Int J Radiat Oncol Biol Phys. 54:2002;886-894.
17. Janssens M.Y., Van den Berge D.L., Verovski V.N., et al. Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res. 58:1998;5646-5648.
18. Mitchell J.B., Wink D.A., DeGraff W., et al. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res. 53:1993;5845-5848.
19. Verovski V.N., Van den Berge D.L., Soete G.A., et al. Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br J Cancer. 74:1996;1734-1742.
20. Janssens M.Y., Verovski V.N., Van den Berge D.L., et al. Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br J Cancer. 79:1999;1085-1089.
21. Van den Berge D.L., De Ridder M., Verovski V.N., et al. Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase. Br J Cancer. 84:2001;1122-1125.
22. Melillo G., Musso T., Sica A., et al. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med. 182:1995;1683-1693.
23. Yang X., Sheares K.K., Davie N., et al. Hypoxic induction of COX-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 27:2002;688-696.
24. Futaki N., Takahashi S., Yokoyama M., et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
25. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases Structure, function and inhibition . Biochem J. 357:2001;593-615.
26. Plaisance S., Vanden Berghe W., Boone E., et al. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol. 17:1997;3733-3743.
27. Oda M., Sakitani K., Kaibori M., et al. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes. J Biol Chem. 275:2000;4369-4373.
28. Reisser D., Pance A., Jeannin J.F. Mechanisms of the antitumoral effect of lipid A. Bioessays. 24:2002;284-289.
29. Onier N., Hilpert S., Reveneau S., et al. Expression of inducible nitric oxide synthase in tumors in relation with their regression induced by lipid A in rats. Int J Cancer. 85:1999;755-760.
30. Mizushima Y., Sassa K., Fujishita T., et al. Therapeutic effect of a new synthetic lipid A analog (ONO-4007) on a tumor implanted at different sites in rats. J Immunother. 22:1999;401-406.
31. Thomsen L.L., Miles D.W., Happerfield L., et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer. 72:1995;41-44.
32. Ambs S., Merriam W.G., Bennett W.P., et al. Frequent nitric oxide synthase-2 expression in human colon adenomas Implication for tumor angiogenesis and colon cancer progression . Cancer Res. 58:1998;334-341.
33. Ristimaki A., Honkanen N., Jankala H., et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1997;1276-1280.
34. Hwang D., Scollard D., Byrne J., et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 90:1998;455-460.
35. Gaffney D.K., Holden J., Davis M., et al. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys. 49:2001;1213-1217.
36. Petersen C., Petersen S., Milas L., et al. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res. 6:2000;2513-2520.
37. Shah T., Ryu S., Lee H.J., et al. Pronounced radiosensitization of cultured human cancer cells by COX inhibitor under acidic microenvironment. Int J Radiat Oncol Biol Phys. 53:2000;1314-1318.
38. Hall E.J. Radiobiology for the radiobiologist. 5th ed:2000;Lippincott Williams & Wilkins, Philadelphia.
39. Bradbury C.M., Markovina S., Wei S., et al. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res. 61:2001;7689-7696.
40. De Ridder M., Van den Berge D.L., Verovski V.N., et al. NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase. Br J Cancer. 88:2003;120-124.
41. Taylor B.S., Liu S., Villavicencio R.T., et al. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. Hepatology. 29:1999;1199-1207.
42. Bump E.A., Jacobs G.P., Lee W.W., Brown J.M. Radiosensitization by diamide analogs and arsenicals. Int J Radiat Oncol Biol Phys. 12:1986;1533-1535.